{"id":"https://openalex.org/W4388420198","doi":"https://doi.org/10.1161/circ.148.suppl_1.13840","title":"Abstract 13840: Safety Outcomes From a First-in-Human Study of a Novel Investigational Monoclonal Antibody, REGN5381, an Agonist to the Natriuretic Peptide Receptor 1","display_name":"Abstract 13840: Safety Outcomes From a First-in-Human Study of a Novel Investigational Monoclonal Antibody, REGN5381, an Agonist to the Natriuretic Peptide Receptor 1","publication_year":2023,"publication_date":"2023-11-06","ids":{"openalex":"https://openalex.org/W4388420198","doi":"https://doi.org/10.1161/circ.148.suppl_1.13840"},"language":"en","primary_location":{"id":"doi:10.1161/circ.148.suppl_1.13840","doi":"https://doi.org/10.1161/circ.148.suppl_1.13840","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1161/circ.148.suppl_1.13840","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027788266","display_name":"Aaron P. Kithcart","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron P Kithcart","raw_affiliation_strings":["Regeneron Pharmaceuticals, Inc., Tarrytown, NY","Aaron P Kithcart Regeneron Pharmaceuticals, Inc., Tarrytown, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals, Inc., Tarrytown, NY","institution_ids":["https://openalex.org/I186523950"]},{"raw_affiliation_string":"Aaron P Kithcart Regeneron Pharmaceuticals, Inc., Tarrytown, NY","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Michael E Dunn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael E Dunn","raw_affiliation_strings":["Regeneron Pharmaceuticals, Inc., Tarrytown, NY","Michael E Dunn Regeneron Pharmaceuticals, Inc., Tarrytown, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals, Inc., Tarrytown, NY","institution_ids":["https://openalex.org/I186523950"]},{"raw_affiliation_string":"Michael E Dunn Regeneron Pharmaceuticals, Inc., Tarrytown, NY","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111776651","display_name":"J. N. J. M. De Hoon","orcid":"https://orcid.org/0000-0002-5215-9836","observed_orcids":["https://orcid.org/0000-0002-5215-9836"]},"institutions":[{"id":"https://openalex.org/I2800231306","display_name":"Universitair Ziekenhuis Leuven","ror":"https://ror.org/0424bsv16","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2800231306"]},{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Jan de Hoon","raw_affiliation_strings":["Cntr for Clinical Pharmacology, Univ Hosps Leuven, Leuven, Belgium","Jan de Hoon Cntr for Clinical Pharmacology, Univ Hosps Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cntr for Clinical Pharmacology, Univ Hosps Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I2800231306","https://openalex.org/I99464096"]},{"raw_affiliation_string":"Jan de Hoon Cntr for Clinical Pharmacology, Univ Hosps Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I2800231306","https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032282905","display_name":"Wouter Botermans","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800231306","display_name":"Universitair Ziekenhuis Leuven","ror":"https://ror.org/0424bsv16","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2800231306"]},{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Wouter Botermans","raw_affiliation_strings":["Cntr for Clinical Pharmacology, Univ Hosps Leuven, Leuven, Belgium","Wouter Botermans Cntr for Clinical Pharmacology, Univ Hosps Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cntr for Clinical Pharmacology, Univ Hosps Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I2800231306","https://openalex.org/I99464096"]},{"raw_affiliation_string":"Wouter Botermans Cntr for Clinical Pharmacology, Univ Hosps Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050210686","display_name":"Satyajit K. Karnik","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Satyajit Karnik","raw_affiliation_strings":["Regeneron Pharmaceuticals, Inc., Tarrytown, NY","Satyajit Karnik Regeneron Pharmaceuticals, Inc., Tarrytown, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals, Inc., Tarrytown, NY","institution_ids":["https://openalex.org/I186523950"]},{"raw_affiliation_string":"Satyajit Karnik Regeneron Pharmaceuticals, Inc., Tarrytown, NY","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081351380","display_name":"Michael E. Burczynski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael E Burczynski","raw_affiliation_strings":["Regeneron Pharmaceuticals, Inc., Tarrytown, NY","Michael E Burczynski Regeneron Pharmaceuticals, Inc., Tarrytown, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals, Inc., Tarrytown, NY","institution_ids":["https://openalex.org/I186523950"]},{"raw_affiliation_string":"Michael E Burczynski Regeneron Pharmaceuticals, Inc., Tarrytown, NY","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Wenjun Zheng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wenjun Zheng","raw_affiliation_strings":["Regeneron Pharmaceuticals, Inc., Tarrytown, NY","Wenjun Zheng Regeneron Pharmaceuticals, Inc., Tarrytown, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals, Inc., Tarrytown, NY","institution_ids":["https://openalex.org/I186523950"]},{"raw_affiliation_string":"Wenjun Zheng Regeneron Pharmaceuticals, Inc., Tarrytown, NY","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111808189","display_name":"Andrew J. Rankin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew J Rankin","raw_affiliation_strings":["Regeneron Pharmaceuticals, Inc., Tarrytown, NY","Andrew J Rankin Regeneron Pharmaceuticals, Inc., Tarrytown, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals, Inc., Tarrytown, NY","institution_ids":["https://openalex.org/I186523950"]},{"raw_affiliation_string":"Andrew J Rankin Regeneron Pharmaceuticals, Inc., Tarrytown, NY","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085084466","display_name":"Gary A. Herman","orcid":"https://orcid.org/0000-0003-4433-6529","observed_orcids":["https://orcid.org/0000-0003-4433-6529"]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary Herman","raw_affiliation_strings":["Regeneron Pharmaceuticals, Inc., Tarrytown, NY","Gary Herman Regeneron Pharmaceuticals, Inc., Tarrytown, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals, Inc., Tarrytown, NY","institution_ids":["https://openalex.org/I186523950"]},{"raw_affiliation_string":"Gary Herman Regeneron Pharmaceuticals, Inc., Tarrytown, NY","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011494147","display_name":"Benjamin A. Olenchock","orcid":"https://orcid.org/0000-0002-8956-5117","observed_orcids":["https://orcid.org/0000-0002-8956-5117"]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Benjamin Olenchock","raw_affiliation_strings":["Regeneron Pharmaceuticals, Inc., Tarrytown, NY","Benjamin Olenchock Regeneron Pharmaceuticals, Inc., Tarrytown, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals, Inc., Tarrytown, NY","institution_ids":["https://openalex.org/I186523950"]},{"raw_affiliation_string":"Benjamin Olenchock Regeneron Pharmaceuticals, Inc., Tarrytown, NY","institution_ids":["https://openalex.org/I186523950"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"148","issue":"Suppl_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.9556000232696533,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.9556000232696533,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.009800000116229057,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.008700000122189522,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.9010000228881836},{"id":"https://openalex.org/keywords/natriuretic-peptides","display_name":"natriuretic peptides","score":0.8619999885559082},{"id":"https://openalex.org/keywords/first-in-human-safety","display_name":"first-in-human safety","score":0.7279999852180481},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.8389999866485596},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.8199999928474426},{"id":"https://openalex.org/keywords/hemodynamic-effects","display_name":"hemodynamic effects","score":0.7210000157356262},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.5320000052452087},{"id":"https://openalex.org/keywords/heart-failure","display_name":"heart failure","score":0.7369999885559082},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.5770000219345093},{"id":"https://openalex.org/keywords/single-ascending-dose","display_name":"single ascending dose","score":0.652999997138977},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.8410000205039978},{"id":"https://openalex.org/keywords/postural-dizziness","display_name":"postural dizziness","score":0.8029999732971191},{"id":"https://openalex.org/keywords/headache","display_name":"headache","score":0.9380000233650208},{"id":"https://openalex.org/keywords/hypotension","display_name":"hypotension","score":0.47699999809265137},{"id":"https://openalex.org/keywords/sodium-excretion","display_name":"sodium excretion","score":0.5509999990463257}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8906950950622559},{"id":"https://openalex.org/C2775915353","wikidata":"https://www.wikidata.org/wiki/Q1571529","display_name":"Natriuretic peptide","level":3,"score":0.7266565561294556},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7113227844238281},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.710628867149353},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5894373655319214},{"id":"https://openalex.org/C174459258","wikidata":"https://www.wikidata.org/wiki/Q6980232","display_name":"Natriuresis","level":3,"score":0.5146785378456116},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.5034059882164001},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5017445087432861},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.4671337902545929},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.43079009652137756},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.40738430619239807},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.36026155948638916},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.25839030742645264},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.22882407903671265},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.09094682335853577},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1161/circ.148.suppl_1.13840","doi":"https://doi.org/10.1161/circ.148.suppl_1.13840","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1161/circ.148.suppl_1.13840","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4415791835","https://openalex.org/W7103756119","https://openalex.org/W4415791866","https://openalex.org/W4402439284","https://openalex.org/W4415793442","https://openalex.org/W7163203843","https://openalex.org/W7163216055","https://openalex.org/W4393976612","https://openalex.org/W2057689437","https://openalex.org/W4408964455"],"abstract_inverted_index":{"Introduction:":[0],"Natriuretic":[1],"peptides":[2],"(NPs)":[3],"regulate":[4],"vascular":[5],"volume":[6],"and":[7,28,33,36,71,103,137,140,151,167,184,211,253,263,330],"tone":[8],"via":[9],"the":[10,100,145,182,188,209,215,240,273,279,298],"membrane-bound":[11],"guanylate":[12],"cyclase,":[13],"natriuretic":[14],"peptide":[15],"receptor":[16],"1":[17],"(NPR1).":[18],"Activation":[19],"of":[20,50,81,129,157,171,237,306,318,325],"this":[21],"pathway":[22],"is":[23,85,327],"known":[24],"to":[25,92,123,165,169,202,229],"lower":[26],"systemic":[27],"venous":[29],"blood":[30],"pressure":[31],"(BP)":[32],"effect":[34],"natriuresis":[35],"diuresis.":[37],"Previous":[38],"recombinant":[39],"NP":[40],"infusions":[41],"for":[42,147],"heart":[43],"failure":[44],"were":[45,160,163,243,266,289],"limited":[46],"by":[47,235],"their":[48],"duration":[49,317],"effects.":[51,334],"REGN5381,":[52],"a":[53,76,125,135,302],"novel":[54],"investigational":[55],"NPR1":[56],"agonist":[57],"monoclonal":[58],"antibody,":[59],"showed":[60],"sustained":[61,311,332],"hemodynamic":[62,333],"effects":[63],"in":[64,89,106,144,181,187,208,214,239,268,272,278,291],"animal":[65],"models.":[66],"Here,":[67],"we":[68],"report":[69],"safety":[70,152],"pharmacodynamic":[72],"(PD)":[73],"outcomes":[74],"from":[75],"phase":[77],"1,":[78],"first-in-human":[79],"study":[80,114,221],"REGN5381.":[82],"Hypothesis:":[83],"REGN5381":[84,104,130,173,190,217,326],"sufficienty":[86],"well":[87],"tolerated":[88],"healthy":[90,117],"humans":[91],"warrant":[93],"continued":[94],"clinical":[95],"investigation.":[96],"Aim:":[97],"To":[98],"assess":[99],"safety,":[101],"tolerability,":[102],"PD":[105],"normotensive":[107],"humans.":[108],"Methods:":[109],"This":[110],"double-blind,":[111],"single-ascending":[112],"dose":[113,128,174,203,230,293,300,324],"(NCT04506645),":[115],"randomized":[116,164],"adults":[118],"aged":[119],"18-55":[120],"years":[121],"(6:2)":[122],"receive":[124],"single":[126,323],"intravenous":[127],"or":[131,284,287],"placebo.":[132],"Participants":[133,295],"received":[134],"fixed-sodium":[136],"fluid":[138],"diet":[139],"remained":[141],"4":[142,260,269],"days":[143],"clinic":[146],"non-invasive":[148],"hemodynamics":[149],"monitoring":[150],"assessment.":[153],"Results:":[154],"A":[155,322],"total":[156,189,216,241,249,258,274],"48":[158],"participants":[159,180,207,238,271],"enrolled;":[161],"12":[162],"placebo":[166,183,210,280],"6":[168,172,251],"each":[170],"levels":[175],"(total":[176],"n=36).":[177],"Eight":[178],"(66.7%)":[179,186],"24":[185],"group":[191,218],"reported":[192,219,267,290],"\u22651":[193,220],"treatment-emergent":[194],"adverse":[195],"event":[196],"(TEAE),":[197],"with":[198,225,297],"no":[199,226],"obvious":[200,227],"relationship":[201,228],"level.":[204,231],"Four":[205],"(33.3%)":[206],"15":[212],"(41.7%)":[213],"drug":[222],"related":[223],"TEAE,":[224],"Common":[232],"TEAEs":[233,286],"(experienced":[234],">10%":[236],"group)":[242],"postural":[244],"dizziness":[245],"(placebo:":[246,255],"2":[247],"[16.7]%;":[248],"REGN5381:":[250,259],"[16.7]%)":[252],"headache":[254],"5":[256],"[41.7%];":[257],"[11.1%]).":[261],"Pyuria":[262],"orthostatic":[264],"hypotension":[265],"(11.1%)":[270],"group,":[275],"but":[276],"none":[277],"group.":[281],"No":[282],"serious":[283],"severe":[285],"deaths":[288],"any":[292],"groups.":[294],"treated":[296],"highest":[299],"saw":[301],"7-11":[303],"mmHg":[304],"reduction":[305],"systolic":[307],"BP":[308],"that":[309],"was":[310],"over":[312],"72":[313],"hours":[314],"(the":[315],"full":[316],"inpatient":[319],"monitoring).":[320],"Conclusion:":[321],"generally":[328],"well-tolerated":[329],"provides":[331]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2023-11-07T00:00:00"}